Relmada Therapeutics
RLMD
RLMD
87 hedge funds and large institutions have $263M invested in Relmada Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 13 closing their positions.
Holders
87
Holders Change
+2
Holders Change %
+2.35%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
36
Reduced
12
Closed
13
Calls
$5.55M
Puts
$785K
Net Calls
+$4.76M
Net Calls Change
-$3M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$11.8M |
| 2 |
2
Millennium Management
New York
|
$6.67M |
| 3 |
GTC
3
Ghost Tree Capital
New York
|
$5.24M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$24M |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$5.27M |
